Cited by 469Advanced Materials and MechanicsPolymer composites and self-healingHydrogels: synthesis, properties, applications

Shape-memory polymers as a technology platform for biomedical applications

Open access
Lendlein, Andreas, Behl, Marc, Hiebl, Bernhard, Wischke, Christian·2010·Expert Review of Medical Devices

Abstract

Polymeric materials are clinically required for medical devices, as well as controlled drug delivery systems. Depending on the application, the polymer has to provide suitable functionalities, for example, mechanical functions or the capability to actively move, so that an implant can be inserted in a compact shape through key-hole incisions and unfold to its functional shape in the body. Shape-memory polymers, as described herein regarding their general principle, compositions and architectures, have developed to a technology platform that allows the tailored design of such multifunctionality. In this way, defined movements of implants triggered either directly or indirectly, tailored mechanical properties, capability for sterilization, biodegradability, biocompatibility and controlled drug release can be realized. This comprehensive review of the scientific and patent literature illustrates that this technology enables the development of novel medical devices that will be clinically evaluated in the near future.

AI snapshot

Written from the paper’s full text.

TL;DR

This review presents shape-memory polymers as a tunable materials platform for biomedical devices, combining programmable shape change with functions such as biodegradability, sterilization compatibility, and controlled drug release. It surveys polymer architectures, device prototypes, biocompatibility testing, and regulatory considerations, while noting that most applications remain preclinical or patent-stage.

Key findings

  • Thermally triggered shape-memory polymers can be fixed in a temporary shape and later recover a permanent shape when heated; the effect depends on a polymer network with netpoints and switchable segments, and can be quantified by shape fixity (Rf) and shape recovery (Rr).
  • Reported material examples include a polyetherurethane with a glass transition near 74°C, Rf of 100%, and Rr of 80% after the third cycle at 50% elongation; PDC multiblock copolymers with hard-segment contents from 0 to 83 wt%, elongation at break up to 1000%, Rf of 98–99.5%, and Rr approaching 100%; polydepsipeptide/PCL copolymers with Rf and Rr above 96% and switching near body temperature; N-PCLDMA networks with Rr of 92–97% and Rf of 86–97% after five cycles; and N-PCGDMA networks with Rf above 96% and Rr of 86% after five cycles at 150% elongation.
  • Drug-loaded SMP matrices have been demonstrated: PCGDMA networks showed low swelling-based loading below 0.8 wt% but up to about 6 wt% when drug was suspended during crosslinking; oLG networks reached up to 2.6 wt%; one PCL-derived system released about 20% of loaded drug in the first day and then released over five weeks.
  • Sterilization and biocompatibility findings are mixed: ethylene oxide is described as the low-temperature standard, while low-temperature plasma sterilization caused cytotoxic effects in some acrylate-based SMPs and plasma-treated PCL/BA was toxic to L929 cells; other sterilized PCL- or polyurethane-based SMPs showed promising non-cytotoxic and histocompatible results, and PCL/BA-based SMPs supported angiogenesis and regeneration of a stomach wall defect in rats.

Methods

  • Design: narrative review of scientific and patent literature, with no primary experimental study or systematic search protocol reported.
  • Data/sample: published polymer chemistry, shape-memory characterization, sterilization and cytotoxicity studies, in vivo animal studies, device prototypes, and patent applications.
  • Main analysis: the authors describe the general mechanism of thermally induced shape memory, categorize SMP architectures by crosslinking type and thermal transition, and discuss biomedical device concepts, drug-release matrices, regulatory classification, and future translation.

Limitations

  • The paper states that only a few studies address cell and histocompatibility of SMPs after sterilization, that drug-loaded SMP contributions remain limited with few practical examples, and that some device applications are described only briefly in patent literature.
  • The paper also states that no single animal species is an ideal general model for humans and that in vitro systems cannot replicate whole-body biodynamics, biotransformation, or excretion.
  • Evident from the text: this is a narrative review without a described systematic search or inclusion criteria, and many device concepts are prototypes or patent-stage ideas rather than clinically evaluated products, so reported performance may not generalize across materials, sterilization methods, or anatomical sites.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1586/erd.10.8

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

9 of 104 cited sources checked · 4 supported · 0 flagged · accuracy not yet measured

  • Premisecitation
    § Multiblock copolymers with T trans = T g

    Incorporation of silica-coated magnetic nanoparticles of iron(III)oxide core into Tecoflex enabled the remote actuation of the thermally induced shape-memory effect in alternating magnetic fields.

    “The incorporation of silica-coated magnetic nanoparticles of iron(III)oxide core into Tecoflex ® enabled the remote actuation of the thermally induced SME in alternating magnetic fields [19].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [19] Mohr, 2006, Proc. Natl Acad. Sci. USA source
  • Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    Ethylene oxide sterilization is the gold standard of low-temperature sterilization methods.

    “The gold standard of the LTS methods is the EO sterilization [66].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [66] Goveia, 2007, Rev. Lat. Am. Enfermagem source
  • Premisecitation
    § External applications

    Indirect heating by laser with optimized coupling of laser light into a dye-loaded SMP corkscrew has in principle been proven suitable to induce shape recovery in air.

    “In further detailed studies with thermoplastic SMPs, indirect heating by laser with an optimized coupling of laser light into a dye-loaded SMP corkscrew has in principle been proven as suitable to induce shape recovery in air [114].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [114] Small, 2005, IEEE J. Sel.Top. Quant. Electron. source

      The Laser Actuation section reports complete recovery of an ICG-dyed SMP corkscrew in air, supporting the proof-of-principle claim. But it also reports intermittent failures from overheating at the fiber–SMP joint; the Heat Distribution section describes tests to improve that joint, not a demonstrated optimized coupling. Page numbers are not available in our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Premisecitation
    § Vascular applications

    When setting water flow rates to values relevant for in vivo applications, the required temperature and complete shape recovery of laser-activated SMP stents has not yet been obtained, even at laser powers up to approximately 8 W, due to cooling by the surrounding medium.

    “While working in principle, when setting the water flow rates to values relevant for in vivo applications, the required temperature and, therefore, a complete shape recovery, has not yet been obtained, even at laser powers up to approximately 8 W due to cooling by the surrounding medium.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [105] Baer, 2007, Biomed. Eng. Online source

      Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Findingcitation
    § Multiblock copolymers with T trans = T g

    In a commercially available polyetherurethane synthesized from methylene bis(p-cyclohexyl isocyanate), 1,4-butanediol, and poly(tetramethyleneoxide) diol, the glass transition temperature is at 74°C.

    “In a commercially available PEU synthesized from methylene bis(p-cyclohexyl isocyanate) (H12 MDI), 1,4-butanediol, and PTMO diol, T g is at 74°C.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [18] Guignot, 2001, Nucl. Instrum. Meth. B source
  • May combine two claims. 64
  • Classified as probably not a substantial claim. 88
  • The quote only partly states this claim. 1
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    Irradiation-based sterilization techniques such as gamma and e-beam sterilization are instantaneous, penetrating and nontoxic, but may be associated with changes in molecular structure.

    “Irradiation-based sterilization techniques such as gand e-beam sterilization are instantaneous, penetrating and nontoxic, but may be associated with changes in the molecular structure [55].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [55] Freeman, 1960, J. Hyg. (Lond.) source

      The Conclusion and Sterilizing technique sections discuss ethylene oxide sterilization, including its long exposure time and the gas’s penetrating power. Searches for irradiation, gamma rays, electron beams, and molecular-structure changes found no passage addressing the claimed properties of irradiation-based sterilization. (LLM, conf=0.75)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Interpretationreasoning
    § External applications

    It might be useful to customize polymers to a lower switching temperature in a narrow range of 45-50°C, rather than using materials of relatively high Tg, to enable activation at lower laser power.

    “Thus, it might be useful to customize polymers to a lower switching temperature in a narrow range of 45-50°C, rather than using materials of relatively high T g in order to enable activation at lower laser power [116].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [116] Wilson TS, Small W, Benett WJ, Bearinger JP, Maitland D. Shape memory polymer therapeutic devices for stroke. In:Smart Medical and Biomedical Sensor Technology III. Cullum BM, Carter JC (Eds). SPIE, WA, USA, 60070R (2005). source

      The Conclusions (page unavailable) report polymers with glass transitions ranging from 34 to 87°C and very narrow transitions, supporting the possibility of tailoring a lower switching temperature. The Coil Stroke Devices section (page unavailable) describes laser actuation, but the paper does not specify a 45–50°C target or say that choosing it would enable activation at lower laser power. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingcitation
    § Miscellaneous internal applications

    Shape recovery from a thin stretched rod to a more compact-shaped rod allows fixation of ligaments in bone tunnels, and the rod's radial recovery forces depend on the material composition, such as the cross-linker content.

    “In this application, shape recovery from a thin stretched rod to a more compact-shaped rod allows fixation of ligaments in bone tunnels, in which the rod's radial recovery forces depend on the material composition, such as the cross-linker content [27].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [27] Yakacki, 2008, Adv. Funct. Mater. source

      The Introduction describes an orthopedic-fixation prototype reduced to a smaller diameter and then heated to recover its shape. The Results and Conclusions link constrained recovery stress to rubbery modulus and crosslink density, which can be adjusted through crosslinking-monomer composition. Our copy does not specify ligament fixation in bone tunnels or measure radial recovery forces in that setting. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation
    § Vascular applications

    By using triple-shape thermosensitive SMP materials, temporary stents could be designed that are implanted in their first temporary shape, expand upon heating to their required functional shape, and upon further heating shrink for easy removal.

    “By using triple-shape thermosensitive SMP materials, temporary stents could be designed that are implanted in their first temporary shape, expand upon heating to their required functional shape (second temporary shape) and, upon further heating, shrink for easy removal if required [102].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [102] Bellin, 2006, Proc. Natl Acad. Sci. USA source
  • May combine two claims.

    Premisecitation
    § Vascular applications

    Tubular SMP devices were laser etched for more flexible stents that could navigate through small tortuous vessels; however, resistance to withstand the critical collapse pressure in the vessel at elevated body temperature may not be given in all cases.

    “In addition, tubular SMP devices were laser etched for more flexible stents that also could navigate through small tortuous vesselshowever, it has been revealed that resistance to withstand the critical collapse pressure in the vessel at elevated body temperature may not be given in all cases [106].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [106] Baer, 2009, J. Biomed. Mater. Res. B Appl. Biomater. source
  • May combine two claims.

    Findingown data
    § SMPs investigated as drug-loaded matrix material

    In cyclic thermomechanical tests, congruent curves were observed for drug-loaded oLG materials during different cycles, meaning that drug loading did not affect the shape-memory functionality.

    “In cyclic thermomechanical tests, congruent curves were observed for drug-loaded materials during the different cycles of testing, meaning that drug loading did not affect the shape-memory functionality.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [131] Wischke, 2009, J. Control. Release source
  • May combine two claims.

    Findingcitation
    § SMPs investigated as drug-loaded matrix material

    Controlled drug release has been established for covalent SMP networks based on different chemistries: PCGDMA cross-linked by photopolymerization, oligo[(rac-lactide)-co-glycolide]tetroles cross-linked by low-molecular-weight aliphatic diisocyanates, and branched oligo(ε-caprolactone)octols cross-linked by low-molecular-weight aliphatic diisocyanates.

    “So far, controlled drug release has been established for covalent SMP networks that were based on different chemistries: PCGDMA as telechelics that were cross-linked by photo polymerization [46,137], oligo[(rac-lactide)-co-glycolide]tetroles (oLG) cross-linked by lowmolecular-weight aliphatic diisocyanates [131,138], and branched oligo(e-caprolactone)octols (oCl) cross-linked by low-molecular”
    Quote in the paperNot a substantial claim0 of 5 sources checked
    • cites [46] Neffe, 2009, Adv. Mater. source
    • cites [137] Neffe, 2009, Mat. Res. Soc. Symp. Proc. source
    • cites [131] Wischke, 2009, J. Control. Release source
    • cites [138] Wischke, 2009, Mat. Res. Soc. Symp. Proc. source
    • cites [132] Nagahama, 2009, Biomacromolecules source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Expert commentary

    A variety of polymers exhibiting a shape-memory effect were prepared and characterized.

    “A variety of polymers exhibiting a SME were prepared and characterized.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation
    § SMPs investigated as drug-loaded matrix material

    Corresponding to the drugs' physicochemical properties, differences in release profiles were observed, with higher release rates for hydrophilic drugs.

    “Corresponding to the drugs' physicochemical properties, differences in the release profiles were observed with higher release rates for hydrophilic drugs.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [131] Wischke, 2009, J. Control. Release source
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Findingnone given
    § Expert commentary

    Shape-memory polymers have attracted substantial scientific and technological interest, especially for biomedical applications, reflected in the rapidly increasing number of publications on SMPs during the last decade.

    “Shape-memory polymers have attracted substantial scientific and technological interest, especially for biomedical applications, which is reflected in the rapidly increasing number of publications on SMPs during the last decade.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Findingnone given
    § point of view.

    Due to a so far limited number of contributions in this field, only a few practical examples of potential applications have been given.

    “Due to a so far limited numbers of contributions in this field, only a few practical examples of potential applications have been given.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given
    § Key issues

    Selected sterilized SMP devices were shown to be non-cytotoxic, as well as cell- and histo-compatible in vitro and in vivo.

    “Selected sterilized SMP devices were shown to be non-cytotoxic, as well as cell-and histo-compatible in vitro and in vivo.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given
    § Key issues

    Currently, only few studies are available that address the cell- and histo-compatibility of SMPs after sterilization.

    “Currently, only few studies are available that address the celland histo-compatibility of SMPs after sterilization.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation
    § SMPs investigated as drug-loaded matrix material

    A clear acceleration of the breakdown of the cross-linked network architecture was observed at least in the presence of some drugs, and the elastic modulus experienced a strong loss during degradation in all drug-loaded samples.

    “However, a clear acceleration of the breakdown of the cross-linked network architecture was observed at least in the presence of some drugs (Figure 10C), and the elastic modulus experienced a strong loss during degradation in all drug-loaded samples (Figure 10D).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [131] Wischke, 2009, J. Control. Release source
  • May combine two claims.

    Findingcitation
    § SMPs investigated as drug-loaded matrix material

    Substantial amounts (up to ~6 wt.%) of suspended drug were incorporated during cross-linking, with only minor effects on the materials' stress-strain curves.

    “Still, substantial amounts (up to ~6 wt.%) of suspended drug were incorporated during cross-linking, with only minor effects on on the materials' stress-strain curves.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [46] Neffe, 2009, Adv. Mater. source
  • May combine two claims.

    Findingcitation
    § SMPs investigated as drug-loaded matrix material

    After an initial release of 20% of the loaded drug in the first day, a smooth subsequent release profile was observed over 5 weeks.

    “After an initial release of 20% of the loaded drug in the first day, a smooth subsequent release profile was observed over 5 weeks (Figure 9B).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [132] Nagahama, 2009, Biomacromolecules source
  • May combine two claims.

    Findingnone given
    § Key issues

    So far, cytotoxicity was evaluated mainly for sterilized polyurethanes or poly(ε-caprolactone)-based SMPs, and showed promising results.

    “So far, cytotoxicity was evaluated mainly for sterilized polyurethanes or poly(e-caprolactone)-based SMPs, and showed promising results.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.

    Findingnone given
    § Five-year view

    Stent technology has been, and certainly will be, one of the most intensively studied fields of SMP applications.

    “Stent technology has been, and certainly will be, one of the most intensively studied fields of SMP applications.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given
    § Key issues

    Within the different strategies to sterilize SMPs, the most commonly used method is low-temperature sterilization with ethylene oxide (EO).

    “Within the different strategies to sterilize SMPs (g-or e-beam-irradiation, hydrogen peroxide vapor-, low-temperature gas plasma-and low-temperature gas-sterilization), the most commonly used method is the low-temperature sterilization with EO.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Findingnone given
    § Key issues

    Very recently, some first reports were published proving the general capability of SMPs for controlled drug release, and led to multifunctional materials that combine shape-memory, biodegradability and controlled drug release.

    “Very recently, some first reports were published proving the general capability of SMPs for controlled drug release, and led to multifunctional materials that combine shape-memory, biodegradability and controlled drug release.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given
    § Five-year view

    The economic significance of this market is reflected in a forecasted revenue of US$4-5 billion in the USA in 2009.

    “The economic significance of this market is reflected in a forecasted revenue of US$4-5 billion in the USA in 2009.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given
    § Key issues

    An evaluation strategy has been established to allow the transfer of shape-memory materials into pharmaceutical sciences.

    “An evaluation strategy has been established to allow the transfer of shape-memory materials into pharmaceutical sciences.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Review

    Shape-memory properties are quantified in cyclic, stimuli-specific mechanical tests that consist of the shape-memory creation process and the recovery of the original, permanent shape.

    “The shape-memory properties are quantified in cyclic, stimuli-specific mechanical tests that consist of the SMCP and the recovery of the original, permanent shape [2,[14][15][16].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [2,[14][15][16]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Classified as probably not a substantial claim.

    Premisenone given
    § Motivation for introduction of SMP to biomedical applications

    Thermally induced shape-memory polymers are triggered by heat.

    “Here, we focus on thermally induced SMPs, which are triggered by heat.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisenone given
    § Examples for shape-memory polymer systems intended for biomedical applications

    Covalent shape-memory polymer networks provide in many cases higher shape fixity and shape recovery ratios compared with similar thermoplastic architectures, while thermoplastic shape-memory polymers provide the advantage of processing by extrusion.

    “While covalent SMP networks provide in many cases higher R f and R r compared with similar thermoplastic architectures, thermoplastic SMPs provide the advantage of processing by extrusion.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Review

    Different test protocols differ in the shape-memory creation process, which can be performed under constant strain or constant stress conditions.

    “Different test protocols have been developed.They differ in SMCP, which can be performed under constant strain or constant stress conditions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given
    § Motivation for introduction of SMP to biomedical applications

    Often the shape-memory effect needs to be combined with other functions, such as degradability or drug release.

    “Often the SME needs to be combined with other functions, such as degradability or drug release.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Sterilization & in vitro cytotoxicity testing

    Oxidation reactions can occur between amine groups and hydrogen peroxide, and cross-linking reactions can occur between ethylene oxide and hydroxyl or amine groups in shape-memory polymers.

    “Possible examples are oxidation reactions, for example, between amine groups and hydrogen peroxide, or cross-linking reactions between EO and hydroxyl or amine groups.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § General principle of SMPs

    Physical cross-linking is realized by solidification on cooling, such as vitrification or crystallization.

    “Physical cross-linking is realized by solidification, which occurs on cooling, such as vitrification or crystallization.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisereasoning
    § Review

    From the data obtained, the shape fixity ratio and the shape recovery ratio can be determined.

    “From the data obtained, the shape fixity ratio (R f ) and the shape recovery ratio (R r ) can be determined.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    The molecular weight of PLG decreases after gamma-irradiation, and this degradation process continues on storage for 4 weeks.

    “The molecular weight of PLG, which is known as a candidate material for SMP synthesis, decreases after g-irradiation, and this degradation process continues on storage for 4 weeks [57,58,61].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [57] Loo, 2005, Biomaterials source
    • cites [58] Williams, 2006, Polym. Degrad. Stab. source
    • cites [61] Leonard, 2006, Plast. Rubber Compos. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Examples for shape-memory polymer systems intended for biomedical applications

    Shape-memory polymers can be considered as multifunctional materials when the shape-memory effect and hydrolytic degradability are present in one material.

    “Additionally, SMPs can be considered as multi functional materials when, for example, the SME and hydrolytic degradability are present in one material.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisenone given
    § Examples for shape-memory polymer systems intended for biomedical applications

    Biomedical applications require certain properties or functionalities that can be fulfilled by the appropriate choice of suitable shape-memory polymer architectures.

    “With respect to SMPs, biomedical applications require certain properties or functionalities, which can be fulfilled by the appropriate choice of suitable SMP architectures.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisereasoning
    § General principle of SMPs

    In multiphase polymers, domains related to the highest thermal transition temperature are hard domains and act as physical netpoints.

    “In such multiphase polymers, the domains related to the highest thermal transition temperature (T perm ) are called hard domains and are acting as physical netpoints.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § General principle of SMPs

    The deformation creating the temporary shape necessitates a sufficient elastic deformability of the polymer network.

    “The deformation creating the temporary shape necessitates a sufficient elastic deformability of the polymer network.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § General principle of SMPs

    Thermosensitive shape-memory polymers are presently the most prominent class of shape-memory polymers.

    “Thermosensitive SMPs, which is presently the most prominent class of SMPs, can be additionally classified according to the thermal transitions related to the solidification of the polymer chain segments.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning
    § Motivation for introduction of SMP to biomedical applications

    The temporary shape of a shape-memory polymer implant can be adjusted to the individual needs of the patient.

    “Furthermore, the temporary shape can be adjusted to the individual needs of the patient.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Review

    The shape fixity ratio is a measure for the ability of the switching segment to fix a mechanical deformation applied during the shape-memory creation process when the temporary shape is created.

    “R f is a measure for the ability of the switching segment to fix a mechanical deformation -for example, an elongation to e m , applied during SMCP, when the temporary shape is created.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    For PCL, e-beam irradiation at 9.0 kGy/min broadens the molecular weight distribution through combined chain scission and cross-linking.

    “For PCL, Filipczak et al. demonstrated by e-beam irradiation (9.0 kGy/min) that the molecular weight distribution becomes broadened through combined chain scission and cross-linking [56].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [56] Filipczak, 2006, Macromol. Biosci. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Multiblock copolymers with T trans = T g

    The application of the prepolymer method enabled the production of thermoplastic polyurethane elastomers on an industrial scale.

    “The application of the prepolymer method enabled the production of thermoplastic polyurethane elastomers on an industrial scale.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given
    § Multiblock copolymers with T trans = T g

    Thermoplastic shape-memory polymers can be synthesized by direct coupling of presynthesized polymer blocks with a reactive linker, by applying the prepolymer method, or by melt blending.

    “Thermoplastic SMPs can be synthesized by direct coupling of presynthesized polymer blocks with a reactive linker, by applying the prepolymer method or by melt blending.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given
    § Examples for shape-memory polymer systems intended for biomedical applications

    Appropriate sterilization of shape-memory polymers requires a transition temperature higher than the temperature attained during the sterilization technique.

    “This requires, for example, a T trans of the SMP, which is higher than the temperature attained during the sterilization technique.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Multiblock copolymers with T trans = T g

    This polyetherurethane material is used in artificial hearts, wound dressings and pacemaker leads.

    “This material is used in artificial hearts, wound dressings and pacemaker leads [18].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [18] Guignot, 2001, Nucl. Instrum. Meth. B source
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § Multiblock copolymers with T trans = T g

    The quality of phase separation between the polyurethane segments and the polyetherurethane is determined by the molecular weight of the polytetrahydrofurandiols used as educt.

    “The quality of phase separation between the polyurethane segments and the PEU is determined by the molecular weight of the polytetrahydrofurandiols used as educt.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Examples for shape-memory polymer systems intended for biomedical applications

    For sterilization techniques using reactive components, building blocks nonreactive towards these components have to be used.

    “Furthermore, in case of sterilization techniques using reactive components, building blocks, which are nonreactive towards these components, have to be used.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Sterilization & in vitro cytotoxicity testing

    Such reactions might shift the transition temperature of a shape-memory polymer, causing actuation during sterilization or preventing actuation at the application site.

    “While these effects might be neglected for materials not intended to change their shape, in case of SMPs, such reactions might result in an undesired shift of T trans , either resulting in actuation of the SME during sterilization or preventing it at the application site, when stimulated by exposure to the intended temperature range.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § General principle of SMPs

    Shape-memory polymers are polymer materials that can be temporarily stabilized in a second, temporary shape by application of external stress and subsequent fixation.

    “SMPs are polymer materials, which can be temporarily stabilized in a second, temporary shape by application of external stress and subsequent fixation [2][3][4][5][6][7][8][9][10][11][12][13].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [2][3][4][5][6][7][8][9][10][11][12][13]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisereasoning
    § General principle of SMPs

    When the shape-memory polymer is reheated, crystallites melt or glassy polymer chain segments return to the viscous state.

    “When the SMP is reheated, the crystallites will melt or the glassy polymer chain segments will return to the viscous state.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisereasoning
    § General principle of SMPs

    Physical crosslinks require a morphology consisting of at least two segregated domains, for example a crystalline and an amorphous phase.

    “physical crosslinks require a morphology consisting of at least two segregated domains -for example, a crystalline and an amorphous phase.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Motivation for introduction of SMP to biomedical applications

    A bulky implant with a switching temperature between room temperature and body temperature can be inserted through a small incision in a compressed or elongated temporary shape and, upon heating to body temperature, changes into its bulky application-relevant shape.

    “A bulky implant having a switching temperature (T sw ) between room temperature and body temperature could be inserted into the body through a small incision in a compressed or elongated temporary shape.As soon as the implant is placed in the body, it is heated to body temperature and changes into its bulky application-relevant shape.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisereasoning
    § Examples for shape-memory polymer systems intended for biomedical applications

    Several shape-memory polymer network architectures have been invented, each having certain advantages.

    “As a result, several SMP network architectures have been invented, each having certain advantages.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § Review

    If additional cross-links are based on physical interaction, a further distinction according to thermal transition can be made: glass transition, melting transition, or liquid crystalline transition.

    “If these additional cross-links are based on physical interaction, a further distinction according to T trans can be made, which can be a glass transition T g , a melting transition T m or a liquid crystalline transition.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisecitation
    § Examples for shape-memory polymer systems intended for biomedical applications

    Multifunctionality is the unexpected combination of material functions.

    “Multifunctionality is the unexpected combination of material functions [17].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [17] Lendlein, 2005, Clin. Hemorheol. Micro.
  • May combine two claims.

    Premisenone given
    § Multiblock copolymers with T trans = T m

    In polyesterurethanes, the oligourethane segments act as hard segments, while the polyester segments, for example poly(e-caprolactone), form the switching segments.

    “In PESU, the oligourethane segments are acting as hard segments, while the polyester segments, for example, poly(e-caprolactone) (PCL), are forming the switching segments.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Premisenone given
    § Review

    Melting transitions mostly extend over a temperature range between 15 and 20 K, while liquid crystalline transitions can occur in a temperature interval between 1 and 5 K.

    “Melting transitions mostly extend over a temperature range between 15 and 20 K, while liquid crystalline transitions can even occur in a temperature interval between 1 and 5 K.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Review

    The shape recovery ratio determines the ability of the material to memorize its permanent shape.

    “R r determines the ability of the material to memorize its permanent shape.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § Multiblock copolymers with T trans = T g

    In most cases these polymers form a mixed domain acting as a switching phase.

    “In most cases these polymers form a mixed domain acting as a switching phase.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning
    § General principle of SMPs

    The netpoints of the polymer network determine the permanent shape of the shape-memory polymer and can be of chemical or physical nature.

    “The netpoints of the polymer network, which are connected by the chain segments, determine the permanent shape of the SMP and can be of chemical (covalent bonds) or physical (intermolecular interactions) nature.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § Review

    When the recovery process is performed under stress-free conditions, for thermally induced shape-memory polymers the switching temperature can be determined.

    “When the recovery process is performed under stress-free conditions, for thermally induced SMPs the switching temperature T sw , triggering the macro scopic SME, can be determined.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Sterilization & in vitro cytotoxicity testing

    Hydrogen peroxide vapor or ethylene oxide may react with certain chemical groups of shape-memory polymers, so careful selection of sterilization method is required.

    “Among them, a careful selection has to be made, as hydrogen peroxide vapor or EO may react with certain chemical groups of the SMP.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Review

    The temperature at which maximum stress is developed can be determined from recovery processes under constant strain.

    “In addition, the temperature at which maximum stress is developed (T smax ) can be determined from recovery processes under constant strain.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Multiblock copolymers with T trans = T m

    Prominent examples for block copolymers with a melting transition as the transition temperature are polyetherurethane, polyesterurethanes and polyetheresterurethanes.

    “Prominent examples for block copolymers with T trans = T m are PEU, polyesterurethanes (PESU) and polyetheresterurethanes.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Sterilization & in vitro cytotoxicity testing

    Tests with organotypic and regiospecific primary cells are suited to provide more detailed systematic information about SMP-cell interaction in the later medical approach.

    “Tests with organotypic and regiospecific primary cells are suited to provide more detailed systematic information about the SMP-cell interaction in the later medical approach.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationcitation
    § Sterilization & in vitro cytotoxicity testing

    These results were supposed to be affected by different mechanical loading by surface roughness, and besides chemical composition, also by resulting surface properties such as hydrophobicity, which are main predictors of protein adsorption and cell adhesion.

    “These results were supposed to be affected by different mechanical loading by the surface roughness, and besides the chemical composition of the material surface, also by the resulting surface properties, often expressed in terms of hydrophobicity, that are the main predictors of protein adsorption and, thus, cell adhesion [77-79].”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [77] Sigurdson, 2002, J. Biomed. Mater. Res. source
    • cites [78] Singer, 1999, N. Engl. J. Med. source
    • cites [79] Wang, 2004, Pharm. Res. source
  • May combine two claims.

    Premisecitation
    § In vivo tests for histo-compatibility & biofunctionality of shape-memory polymers

    No gas leakage after gas insufflation could be detected, and fast and unfavorable degradation of the polymer did not occur.

    “No gas leakage after gas insufflation could be detected, and fast and unfavorable degradation of the polymer did not occur.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [75] Rickert, 2005, Biomed. Tech. (Berl.) source
    • cites [76] Rickert, 2005, Clin. Hemorheol. Microcirc.

      Not checked in the free run.

    • The authors state this as an assumption: The incorporation of a biomaterial in vivo requires regular wound-healing mechanisms.
  • May combine two claims. The quote only partly states this claim.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    Endothelial cells proved to adhere, grow and form confluent monolayers on PDC after EO sterilization during increasing time periods.

    “The endothelial cells proved to adhere, to grow and to from confluent monolayers on the material during increasing time periods.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [80] Rickert, 2003, Clin. Hemorheol. Microcirc.
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    N-PCLDMA polymer proved biocompatible for all tested cell types, supporting cell viability and proliferation.

    “The polymer proved biocompatibility for all tested cell types, supporting cell viability and proliferation.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [86] Neuss, 2009, Biomaterials source
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    N-PCLDMA supported osteogenic and adipogenic differentiation of human mesenchymal stem cells 3 weeks after induction, and SME activation did not affect the majority of adherent cells.

    “N-PCLDMA also supported the osteogenic and adipogenic differentiation of human mesenchymal stem cells 3 weeks after osteogenic and adipogenic induction, and the SME activation did not affect the majority of adherent cells.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [86] Neuss, 2009, Biomaterials source
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    PESU showed higher TNF-a production and a higher potential for macrophage and endothelial activation compared with PEU.

    “The PESU showed higher TNF-a production and a higher potential for macrophage and endothelial activation, respectively, compared with PEU.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [81] Cabanlit, 2007, Macromol. Biosci. source
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    PCL-based shape-memory polyurethane ionomers with quaternarized pyridine moieties reduced the bacterial activity of Klebsiella pneumoniae by 96.2% and Staphylococcus aureus by 100%.

    “In addition, PCL-based shape-memory polyurethane ionomers with quaternarized pyridine moieties proved to be suited to reduce the bacterial activity of Klebsiella pneumoniae (-96.2%) and Staphylococcus aureus (-100%).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [73] source
  • May combine two claims.

    Premisecitation
    § In vivo tests for histo-compatibility & biofunctionality of shape-memory polymers

    The in vivo degradation process of PDC is characterized by a release of microparticles, which were supposed to primarily consist of PPDO, and which did not negatively affect strong integration of the SMP in the subcutis of rats and mice.

    “The study demonstrated that the in vivo degradation process of PDC is characterized by a release of microparticles, which were supposed to primarily consist of PPDO, and which didn't negatively affect a strong integration of the SMP in the subcutis of rats [97] and mice [99].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [97] Hiebl, 2009, Mat. Res. Soc. Symp. Proc. source
    • cites [99] Binzen, 2003, Clin. Hemorheol. Microcirc.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • The authors state this as an assumption: The incorporation of a biomaterial in vivo requires regular wound-healing mechanisms.
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    Variations in PEU blood compatibility have been observed, with improved thromboresistance correlating to more alkylated soft segments, higher soft segment content on the surface, and surface treatment such as grafted sulfonate groups.

    “Variations in PEU blood compatibility have been observed, with improved thromboresistance correlating to more alkylated soft segments [82], higher soft segment content on the surface [83] and surface treatment, such as grafted sulfonate groups [84,85].”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [82] Coury A, Levy R, McMillin Cet al.Biomaterials Science: An Introduction to Materials in Medicine. Ratner B, Hoffman A, Schoen F, Lemons J (Eds). Academic Press, NY, USA (1996).

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [83] Silver, 1994, Biomaterials source
    • cites [84] Lelah, 1985, J. Biomed. Mater. Res. source
    • cites [85] Lelah, 1983, J. Biomed. Mater. Res. source
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    Polyurethane ionomers possessed good bactericidal activity against Staphylococcus aureus and bacteriostatic activity against Escherichia coli.

    “It was found that the polyurethane ionomers possessed good bactericidal activity against Staphylococcus aureus and bacteriostatic activity against Escherichia coli.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [72] Grapski, 2001, Biomaterials source
  • May combine two claims.

    Premisecitation
    § Sterilization & in vitro cytotoxicity testing

    After plasma sterilization with Sterrad-100St, H2O2, for 52 min, PU foams have increased open porosity but no effects on shape-memory recovery.

    “After plasma sterilization (Sterrad-100St, H 2 O 2 , 52 min) PU foams are described to have an increased open porosity, but no effects on shape-memory recovery were observed [63].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [63] De Nardo, 2009, Acta Biomater. source
  • Classified as probably not a substantial claim.

    Interpretationreasoning
    § In vivo tests for histo-compatibility & biofunctionality of shape-memory polymers

    Therefore, in vivo testing in animal models is necessary prior to human clinical testing.

    “Therefore, in vivo testings in animal models are necessary prior to human clinical testing.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation
    § In vivo tests for histo-compatibility & biofunctionality of shape-memory polymers

    The angiogenic effect of PDC was shown in the hen's egg chorioallantoic membrane test and after subcutaneous implantation in rats and mice.

    “This might be explained by the angiogenic effect of the PDC, which was shown in the hen's egg chorioallantoic membrane test (HET-CAM-test) [71], and also after subcutaneous implantation in rats [97] (Figure 3) and mice [99].”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites [71] Rickert, 2006, Eur. Arch. Otorhinolaryngol. source
    • cites [97] Hiebl, 2009, Mat. Res. Soc. Symp. Proc. source
    • cites [99] Binzen, 2003, Clin. Hemorheol. Microcirc.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • The authors state this as an assumption: The incorporation of a biomaterial in vivo requires regular wound-healing mechanisms.
  • May combine two claims.

    Premisenone given
    § Sterilization & in vitro cytotoxicity testing

    The highest MMP-1 and MMP-2 levels corresponded with the highest TIMP levels, and vice versa.

    “The highest MMP-1 and MMP-2 levels corresponded with the highest TIMP levels, and vice versa.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [74][75][76][77]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation
    § Vascular applications

    By using polymers instead of Pt coils, improved cell adhesion may be achievable, since polymers can be tailored to preferentially allow adhesion of certain cell types by selection of building blocks.

    “By using polymers instead of Pt coils, an improved cell adhesion may be achievable [108], since polymers can be tailored to preferentially allow adhesion of certain cell types by the selection of building blocks for the polymer.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [108] Hampikian, 2006, Mater. Sci. Eng. C source
  • May combine two claims.

    Interpretationreasoning
    § External applications

    Energy input from laser activation also causes heating and potential damages to blood cells and the surrounding tissue.

    “However, at the same time, energy input also causes heating and potential damages to blood cells and the surrounding tissue.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    For hydrolytic cleavage as the most commonly followed biodegradation strategy, the erosion mechanism depends on the combination of the rate of water uptake into the matrix and the rate of hydrolytic polymer cleavage.

    “For example, for hydrolytic cleavage as the most commonly followed biodegradation strategy, the erosion mechanism depends on the combination of both the rate of water uptake into the matrix and the rate of hydrolytic polymer cleavage.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § The concept of controlled drug release from biodegradable polymers

    The concept of a controlled and sustained release of drugs from biodegradable implants was developed more than 30 years ago.

    “The concept of a controlled and sustained release of drugs from biodegradable implants was developed more than 30 years ago [134,135].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [134] source
    • cites [135] source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    Diffusion of water into the polymer matrix typically occurs when the dry implant matrix is transferred into a physiological environment.

    “Typically this is the case when the dry implant matrix is transferred into a physiological environment.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    Depending on the application, drug release can be adjusted to be fast, slow or pulsatile.

    “Depending on the application, the release can be adjusted to be, for example, fast, slow or pulsatile.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § External applications

    FDA approval was received in the USA for a microcatheter system that is guided to the occluded vessel and passed beyond the thrombus; a nitinol wire deploys to a helical corkscrew shape and captures the clot.

    “Accordingly, FDA approval was received in the USA for a microcatheter system that is guided to the occluded vessel and passed beyond the thrombus.A nitinol wire is advanced through the catheter, deploys at the end of the catheter in a spring-like manner to a helical corkscrew shape, and captures the clot [129].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [129] Gobin, 2004, Stroke source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § The concept of controlled drug release from biodegradable polymers

    When drug release and degradation/erosion overlap, diffusion and erosion both contribute to the drug's release profile.

    “In this common scenario, diffusion and erosion both contribute to the drug's release profile.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    In contrast to daily peroral medication, implants can reduce the frequency of administration and provide constant levels of bioactive molecules either locally or systemically over an extended period of time (sustained release).

    “In contrast to daily peroral medication, for example, with tablets, implants can reduce the frequency of administration, and provide constant levels of bioactive molecules either locally or systemically over an extended period of time (sustained release).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    Polymer erosion can occur either at the surface of the material (surface-eroding) or in the entire matrix (bulk-eroding).

    “In principle, this erosion can either occur at the surface of the material (surface-eroding) or in the entire matrix (bulk-eroding).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premiseown data
    § In vivo tests for histo-compatibility & biofunctionality of shape-memory polymers

    A tight connection between the polymer and the adjacent stomach was found, resulting in adequate mechanical stability under the extreme pathophysical conditions of the stomach milieu.

    “A tight connection between the polymer and the adjacent stomach was found, resulting in adequate mechanical stability under the extreme pathophysical conditions of the stomach milieu (Figure 4).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [75] Rickert, 2005, Biomed. Tech. (Berl.) source
    • cites [76] Rickert, 2005, Clin. Hemorheol. Microcirc.

      Not checked in the free run.

    • The authors state this as an assumption: The incorporation of a biomaterial in vivo requires regular wound-healing mechanisms.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § The concept of controlled drug release from biodegradable polymers

    Depending on the speed and pathway of polymer erosion, drug release and degradation/erosion may overlap.

    “Depending on the speed and pathway of polymer erosion, drug release and degradation/erosion may overlap.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § External applications

    Due to Joule heating by applying current to the copper wires, the SMP switching temperature is exceeded and super elastic recovery of the nitinol is enabled.

    “Due to Joule heating by applying current to the copper wires, the SMP switching temperature is exceeded and super elastic recovery of the nitinol is enabled.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [117] Small, 2007, IEEE Trans. Biomed. Eng. source
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Miscellaneous internal applications

    A fast shape recovery may be useful when immediate fixation of a device or tissue is required during an intraoperative scenario.

    “Often, a fast shape recovery may be useful when immediate fixation of a device or tissue is required during an intraoperative scenario.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    For drugs with relevant diffusion coefficients, a solely diffusion-controlled drug release can be realized.

    “For drugs with relevant diffusion coefficients, a solely diffusioncontrolled drug release can be realized.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § External applications

    Preliminary in vivo data in dogs for aneurysms of the common carotid artery showed successful closure, at least macroscopically, in this well-healing vessel model, although no information on the cell types of the neointima was provided.

    “Preliminary in vivo data in dogs for aneurysms of the common carotid artery showed a successful closure, at least macroscopically, in this well-healing vessel model, although no information on the cell types of the neointima was provided (Figure 7) [107].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [107] Metcalfe, 2003, Biomaterials source
  • May combine two claims.

    Premisecitation
    § External applications

    After turning off the current, the SMP vitrifies, enforces the nitinol and allows clot removal in vivo without the need of otherwise common guide wires.

    “After turning off the current, the SMP vitrifies, enforces the nitinol and allows clot removal in vivo without the need of otherwise common guide wires [118].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [118] Hartman, 2007, AJNR Am. J. Neuroradiol.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § The concept of controlled drug release from biodegradable polymers

    A solely erosion-controlled drug release can be observed for molecules that do not possess diffusibility in the polymer matrix, for example due to high molecular weight.

    “A solely erosion-controlled drug release can be observed for molecules that do not possess diffusibility in the polymer matrix; for example, for sterical reasons due to a high molecular weight.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given
    § Miscellaneous internal applications

    Shape recovery produces forces that are typically required to enable the biomedical functionality of SMP devices.

    “Shape recovery produces forces that are typically required to enable the bio medical functionality of SMP devices.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given
    § Miscellaneous internal applications

    By employing SMP devices rather than common metal screws, damage of ligaments by the screw threads may be avoided during fixation.

    “Moreover, by employing SMP devices rather than common metal screws, damage of ligaments by the screw threads may be avoided during fixation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    Diffusion of water from the release medium into the polymer matrix is essential to initiate drug release.

    “It should be pointed out that the diffusion of water from the release medium into the polymer matrix is essential to initiate drug release.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    In SMPs capable of biodegradation, substantial alterations of polymer properties will occur after exposure to a physiological environment.

    “In the preferred case of SMPs with the capability to undergo biodegradation, substantial alterations of polymer properties will occur after exposure to a physiological environment.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § The concept of controlled drug release from biodegradable polymers

    Dissolved drug molecules can diffuse with a certain rate out of a polymer matrix.

    “Generally, dissolved drug molecules can diffuse with a certain rate out of a polymer matrix.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning
    § Potential of SMP as intelligent matrix material for controlled drug-release systems

    Adding a new capability to a device is not trivial, since it may impair an already established functionality.

    “Adding a new capability to a device is not trivial, since it is not unlikely that this may impair an already established functionality.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Vascular applications

    Incorporation of higher amounts of cross-linker into the network, or reducing the Tg of the switching segment, resulted in faster shape recovery of stent prototypes at body temperature in vitro.

    “Incorporation of higher amounts of the cross-linker into the network, or reducing the T g of the switching segment, resulted in faster shape recovery of stent prototypes at body temperature in vitro.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [26] Yakacki, 2007, Biomaterials source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisereasoning
    § The concept of controlled drug release from biodegradable polymers

    Following water diffusion, small-molecule drugs with some water solubility get dissolved and typically can diffuse through the matrix in order to be released.

    “Following this, small-molecule drugs, at least those with some extent of water solubility, get dissolved and typically can diffuse through the matrix in order to be released.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation
    § The concept of controlled drug release from biodegradable polymers

    A controlled-release formulation may prevent drug degradation, reduce side effects, or improve patients' adherence to the treatment.

    “Besides ensuring delivery of the correct amount of drug, a controlled-release formulation may prevent drug degradation, reduce side effects, or improve patients' adherence to the treatment [136].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [136] source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning
    § The concept of controlled drug release from biodegradable polymers

    As a consequence of polymer degradation, implants lose structural integrity, undergoing erosion.

    “As a consequence of polymer degradation, implants lose structural integrity -that is, they undergo erosion.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Vascular applications

    In another study, solid and perforated stents were compared, and a faster onset of recovery was found for the perforated devices.

    “In another study, solid and perforated stents were compared, and a faster onset of recovery was found for the perforated devices [104].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [104] Yakacki CM, Shandas R, Lanning C, Gall K. Free recovery effects of shape-memory polymers for cardiovascular stents. In:Mechanical Behavior of Biological and Biomimetic Materials. Bushby AJ, Ferguson VL, Ko C-C, Oyen ML (Eds). Material Research Society, PA, USA (2006). source
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given
    § Potential of SMP as intelligent matrix material for controlled drug-release systems

    Incorporation of drugs may result in a disturbance of the polymer morphology or thermomechanical properties, and thus in an impaired shape-memory of a temperature-induced SMP.

    “For example, incorporation of drugs may result in a disturbance of the polymer morphology or thermomechanical properties, and thus in an impaired shape-memory of a temperature-induced SMP.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Premisenone given
    § Key issues

    Biomedical applications require specific combinations of properties or functionalities, which can be realized by the appropriate choice of suitable SMP architectures.

    “Biomedical applications require specific combinations of properties or functionalities, which can be realized by the appropriate choice of suitable SMP architectures.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given
    § Key issues

    Multifunctional SMPs that combine shape-memory, biodegradability and controlled drug release are highlighted as matrices of drug carriers with relevance for both medical devices and pharmaceutical products.

    “Multifunctional SMPs that combine shape-memory, biodegradability and controlled drug release are highlighted as matrices of drug carriers with relevance for both medical devices and pharmaceutical products.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Shape-memory polymers as a technology platform for biomedical applications

    Increased drug solubility in the polymer may increase maximum loading by swelling techniques but may also result in incomplete drug release due to trapping of drug in the polymer phase.

    “This, on the one hand, may increase maximum loading, for example, by swelling techniques, but, on the other hand, may result in incomplete drug release due to trapping of drug in the polymer phase.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given
    § Key issues

    The shape-memory effect results from a suitable molecular network architecture in combination with a tailored processing and programming technology.

    “The shape-memory effect (SME) results from a suitable molecular network architecture in combination with a tailored processing and programming technology.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationreasoning
    § point of view.

    If a SMP stent releases drugs and subsequently is removed from the tissue by biodegradation, the stent product might be considered to act mainly as a drug reservoir, and therefore as a pharmaceutical product.

    “If, on the other hand, a SMP stent releases drugs and subsequently is removed from the tissue by biodegradation, the stent product, although providing mechanical stabilization of a tissue for a certain period of time, might be considered to act mainly as a drug reservoir, and therefore as a pharmaceutical product.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given
    § Relevance of SMP architecture & morphology for drug-release applications

    There are several different methods to incorporate drugs in a polymeric matrix, but their applicability depends on the polymer properties.

    “In principle, there are several different methods to incorporate drugs in a polymeric matrix; however, their applicability will depend on the polymer properties.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Premisenone given
    § Key issues

    Selection of building blocks and polymer architectures allows tuning of SMP mechanical properties over a wide range.

    “Selection of building blocks and polymer architectures allows tuning of SMP mechanical properties over a wide range.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § point of view.

    During the consultation process, according to the medical device directive 93/42/EEC, the relevant national authorities will independently review in each specific case whether inclusion of drugs has led to changes in product classification.

    “During the consultation process, according to the medical device directive 93/42/EEC, the relevant national authorities will independently review in each specific case whether inclusion of drugs has led to changes in product classification.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites medical device directive 93/42/EEC

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation
    § Shape-memory polymers as a technology platform for biomedical applications

    Amorphous covalent SMP networks might advantageously show more homogeneous biodegradation, slower changes of mechanical properties during degradation, and easier adjustment of degradation and possibly drug release rates by changing co-monomer ratios in the network precursors.

    “Besides being capable of drug loading in the entire matrix, amorphous covalent SMP networks might advantageously show a more homogeneous biodegradation, slower changes of mechanical properties during degradation and an easier adjustment of degradation, and possibly of drug release rates, by changing the co-monomer ratios in the network precursors [133].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [133] Wischke, 2010, Adv. Polym. Sci.

      Not checked in the free run.

  • May combine two claims.

    Premisenone given
    § Shape-memory polymers as a technology platform for biomedical applications

    Drug loading of thermoplastic materials will typically be time-independent from polymer synthesis and can be carried out with different loading levels.

    “Drug loading will typically be time-independent from polymer synthesis and could be carried out with different loading levels.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Shape-memory polymers as a technology platform for biomedical applications

    Cross-linking a macromolecular network precursor in the presence of dispersed drug might cause chemical alterations of drug molecules that should be strictly avoided.

    “Cross-linking macromolecular network precursor in the presence of dispersed drug might possibly cause chemical alterations of drug molecules that should be strictly avoided.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § point of view.

    Such stents might be useful to keep the ureter open, for example in patients with abdominal tumors.

    “Such stents might be useful to keep the ureter open, for example in patients with abdominal tumors.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given
    § Shape-memory polymers as a technology platform for biomedical applications

    A possibly broader temperature interval of thermal transition or a potential drug-induced plasticization of the SMP, and consequent alterations of the switching temperature, might be drawbacks of amorphous SMP networks.

    “However, a possibly broader temperature interval of thermal transition or a potential drug-induced plasticization of the SMP and, as a consequence of this, alterations of the switching temperature, might be potential drawbacks of amorphous SMP networks.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationreasoning
    § Expert commentary

    Due to SMP biodegradability, the need for a second surgery for explantation can be avoided, which is beneficial for the patient and reduces treatment costs and intraoperative risks.

    “Due to SMP biodegradability, the need of a second surgery for explantation can be avoided, which is beneficial for the patient and reduces treatment costs, as well as intraoperative risks.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisenone given
    § Relevance of SMP architecture & morphology for drug-release applications

    Common strategies to incorporate drugs in a polymeric matrix include casting of drug/polymer solutions, processing polymers in the molten state with dissolved or suspended drug, swelling of preformed networks, or cross-linking a macromolecular network precursor in the presence of dispersed drug.

    “Common strategies include casting of drug/polymer solutions, processing polymers in the molten state with dissolved or suspended drug, swelling of preformed networks or cross-linking a macromolecular network precursor in the presence of dispersed drug.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given
    § Expert commentary

    The introduction of biodegradable building blocks into SMPs enabled a wider evaluation of SMPs for biomedical applications.

    “Importantly, the introduction of biodegradable building blocks into the SMPs enabled a wider evaluation of SMPs for biomedical applications.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Shape-memory polymers as a technology platform for biomedical applications

    Noncovalent interactions, such as ionic bonds or hydrophobic interactions between drug and polymer, may take place when dissolved drug molecules are brought into contact with the polymer during drug loading.

    “In addition, noncovalent interactions, such as ionic bonds or hydrophobic interactions between drug and polymer, may take place when dissolved drug molecules are brought into contact with the polymer during drug loading.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given
    § point of view.

    According to the common definition, at least in Europe, a product will no longer be considered a medical device but a pharmaceutical product whenever a principal intended action of the device in the human body is achieved by pharmacological, immunological or metabolic means.

    “According to the common definition and, at least in Europe, the product will no longer be considered as a medical device, but a pharmaceutical product whenever a principal intended action of the device in the human body is achieved by pharmacological, immunological or metabolic means.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisenone given
    § Shape-memory polymers as a technology platform for biomedical applications

    Drug loading of covalently cross-linked SMP networks can be conducted by swelling the network in drug solutions with subsequent drying.

    “Drug loading of covalently cross-linked SMP networks can be conducted by swelling the network in drug solutions with subsequent drying.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisereasoning
    § point of view.

    To evaluate the significance of the drug payload in a specific product, the purpose and application of the product need to be considered.

    “In order to evaluate the significance of the drug payload in a specific product, the purpose and application of the product need to be considered.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Five-year view

    Biodegradable SMP stents are considered as a future strategy that might overcome complications in treatment, such as late thrombosis.

    “Biodegradable SMP stents are considered as a future strategy that might overcome complications in treatment, such as late thrombosis.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning
    § Key issues

    This stresses the potential of SMP applications in the field of regenerative therapies.

    “This stresses the potential of SMP applications in the field of regenerative therapies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning
    § Five-year view

    These requirements could be fulfilled by materials that are able to perform more than one predetermined shift.

    “These requirements could be fulfilled by materials that are able to perform more than one predetermined shift.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Premisenone given
    § Key issues

    Besides the advantages of EO, including efficacy at low temperatures, high penetration and compatibility with a wide range of materials, residual EO can have severe cytotoxic effects.

    “However, besides the advantages of EO, including efficacy at low temperatures, high penetration and compatibility with a wide range of materials, residual EO can have severe cytotoxic effects.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Premisenone given
    § Five-year view

    Especially for applications in minimally invasive medicine, there is a strong demand for implants that are able to perform complex movements.

    “Especially for applications in minimally invasive medicine, there is a strong demand for implants that are able to perform complex movements.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.

    Interpretationnone given
    § Five-year view

    By combining the SME with biodegradability and controlled drug release in one polymeric system, multifunctional materials can be obtained that open up biomedical applications beyond medical devices.

    “By combining the SME with biodegradability and controlled drug release in one polymeric system, multifunctional materials can be obtained that open up biomedical applications beyond medical devices.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationnone given
    § Five-year view

    In terms of an individual treatment of patients, SMPs might be necessary that can be adapted to the specific conditions of an individual patient.

    “In addition, in terms of an individual treatment of patients, SMPs might be necessary that can be adapted to the specific conditions of an individual patient.”
    Quote in the paperNot a substantial claim
134 of 134
  • The authors state this as an assumption.

    In nonfunctional in vivo tests, acute toxic or inflammatory reactions are nonspecific and may therefore be evaluated in soft tissues such as subcutaneous, intramuscular and intraperitoneal sites.

    “In these tests, it is assumed that acute toxic or inflammatory reactions are nonspecific, and thus may be evaluated in soft tissues (e.g., subcutaneous, intramuscular and intraperitoneal), because implantation in soft tissue requires minor surgery.”
  • The authors state this as an assumption.

    The incorporation of a biomaterial in vivo requires regular wound-healing mechanisms.

    “The incorporation of a biomaterial in vivo is generally assumed to require regular wound-healing mechanisms.”
  • The paper relies on this without support.

    No single animal species represents an ideal general model for the human species.

    “No single animal species represents an ideal general model for the human species.”
  • The paper relies on this without support.

    Drug incorporation is not expected to occur in the crystalline phase.

    “since drug incorporation is not expected to occur in the crystalline phase”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The paper achieved a 4D printable shape memory hydrogel that operates via spinodal decomposition, with shape-shifting dominated by internal mass diffusion instead of thermal conduction.

    “Here, we achieve this seemingly unrealistic goal with a 4D printable shape memory hydrogel that operates via spinodal decomposition, with its shape-shifting dominated by internal mass diffusion instead of thermal conduction for common shape memory polymers8-10,13.”

    From Shape memory polymer with programmable recovery onset (2023) · cites this paper as [8]

    The citation attaches to the comparison with common shape-memory polymers, not to the citing authors’ claim that they achieved a 4D-printable hydrogel. The source’s ‘Motivation for introduction of SMP to biomedical applications’ section says it focuses on polymers triggered by heat, supporting the thermal comparison broadly. It does not establish that their shape-shifting is dominated specifically by thermal conduction; nor does it report the citing authors’ hydrogel, spinodal decomposition, or internal mass diffusion. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Accessing external stimulation under realistic scenarios has become the biggest bottleneck for increasingly demanding applications such as implantable medical devices.

    “Ironically, accessing external stimulation (e.g. heating or light) under realistic scenarios has become the biggest bottleneck for increasingly demanding applications such as implantable medical devices8.”

    From Shape memory polymer with programmable recovery onset (2023) · cites this paper as [8]

    The Five-year view (page unavailable) identifies direct access to implanted materials as a challenge and calls for on-demand actuation independent of body temperature. The Vascular applications section (page unavailable) also reports difficulty achieving light-triggered recovery under flow conditions relevant to in vivo use. The paper does not characterize access to external stimulation as the biggest bottleneck. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Cites

Flagged first, then by citations

19 of the 164 references couldn’t be matched to a known paper.

Research works printed but not linked: 20

  1. Saroop, 2006, Popular Plast. Packag., 51, 73
  2. Behl, 2010, Adv. Polym. Sci.
  3. Wagermaier, 2010, Adv. Polym. Sci.
  4. Lendlein, 2005, Clin. Hemorheol. Micro., 32, 105
  5. Razzaq, 2009, Mat. Res. Soc. Symp. Proc., 1140, 185
  6. Yu, 2009, J. Phys. Chem., 113, 17630
  7. Lendlein, 2001, Proc. Natl Acad. Sci. USA, 98, 842
  8. Block SA.Desinfection, Sterilization, and Preservation. Block SA (Ed.). Williams & Williams, Lippincott, PA, USA (2000).
  9. FDA.Updated 510(k) Sterility Review Guidance K90-1; Guidance for Industry and FDA. US Department Of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation, Rockville, MD, USA (2002).
  10. Lerouge, 2002, Biomed. Mater. Eng., 12, 3
  11. Rickert, 2007, Clin. Hemorheol. Microcirc., 36, 301
  12. Rickert, 2005, Clin. Hemorheol. Microcirc., 32, 117
  13. Rickert, 2003, Clin. Hemorheol. Microcirc., 28, 175
  14. Nicosia, 1999, Int. Rev. Cytol., 185, 1
  15. Binzen, 2004, Clin. Hemorheol. Microcirc., 30, 283
  16. Hiebl, 2009, Mat. Res. Soc. Symp. Proc., 1140, 143
  17. Binzen, 2003, Clin. Hemorheol. Microcirc., 28, 183
  18. Hartman, 2007, AJNR Am. J. Neuroradiol., 28, 872
  19. Jung, 2008, J. Mater. Sci. Mater. Med.
  20. Wischke, 2010, Adv. Polym. Sci.

Cited by

Sorted by citations

Authors
Lendlein, A., Behl, M., Hiebl, B., & Wischke, C.
Affiliations
Berlin-Brandenburger Centrum für Regenerative Therapien (DE)
Venue
Expert Review of Medical Devices
Published
2010-05
Volume
7
Issue
3
Pages
357-379
ISSN
  • 1743-4440 (ISSN-L)
  • 1745-2422
OpenAlex
W2165293299
Cited by
469
References
164
Citations by year
2026: 17 · 2025: 21 · 2024: 34 · 2023: 27 · 2022: 35 · 2021: 31 · 2020: 37 · 2019: 39 · 2018: 25 · 2017: 26 · 2016: 32 · 2015: 29 · 2014: 26 · 2013: 22 · 2012: 23
FWCI
54.07
Type
journal article
Language
en
Open access
Locations
  • Expert Review of Medical Devices (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Mechanical Engineering › Advanced Materials and Mechanics
  • Physical Sciences › Materials Science › Polymers and Plastics › Polymer composites and self-healing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
Keywords
shape memory polymers, biomedical applications, medical devices, controlled drug delivery, biomedical implants, polymer composition, polymer architecture, biodegradability, biocompatibility, sterilization, controlled drug release, patent landscape
MeSH terms
Animals, Equipment and Supplies, Humans, Materials Testing, Polymers, Sterilization, Drug Delivery Systems, Biomedical Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review